This is a Validated Antibody Database (VAD) review about rhesus mac.. FCGR3, based on 57 published articles (read how Labome selects the articles), using FCGR3 antibody in all methods. It is aimed to help Labome visitors find the most suited FCGR3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FCGR3 synonym: CD16; FcRIII

BioLegend
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 5e
BioLegend FCGR3 antibody (Biolegend, 302038) was used in flow cytometry on human samples (fig 5e). J Immunother Cancer (2022) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; 1:100; loading ...; fig 6b
BioLegend FCGR3 antibody (Biolegend, 302012) was used in flow cytometry on human samples at 1:100 (fig 6b). Nat Nanotechnol (2022) ncbi
mouse monoclonal (3G8)
  • blocking or activating experiments; human; 5 ug/ml; loading ...; fig s4
BioLegend FCGR3 antibody (Biolegend, 3G8) was used in blocking or activating experiments on human samples at 5 ug/ml (fig s4). BMC Biol (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...
BioLegend FCGR3 antibody (Biolegend, 302035) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 7
BioLegend FCGR3 antibody (Biolegend, 302019) was used in flow cytometry on human samples (fig 7). PLoS Negl Trop Dis (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; 1:200; loading ...; fig s1a
BioLegend FCGR3 antibody (Biolegend, 302029) was used in flow cytometry on human samples at 1:200 (fig s1a). Arthritis Res Ther (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...
BioLegend FCGR3 antibody (BioLegend, 302044) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...
BioLegend FCGR3 antibody (Biolegend, 302008) was used in flow cytometry on human samples . BMC Biol (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s9d
BioLegend FCGR3 antibody (BioLegend, 302040) was used in flow cytometry on human samples (fig s9d). Nature (2021) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s3a
BioLegend FCGR3 antibody (Biolegend, 302057) was used in flow cytometry on human samples (fig s3a). Cell Rep (2020) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 3c
BioLegend FCGR3 antibody (Biolegend, 302042) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 4b
BioLegend FCGR3 antibody (Biolegend, clone 3G8) was used in flow cytometry on human samples (fig 4b). Sci Rep (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s1a
BioLegend FCGR3 antibody (BioLegend, 302051) was used in flow cytometry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 6
BioLegend FCGR3 antibody (BioLegend, 302011) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (3G8)
  • other; human; loading ...; fig 4b
BioLegend FCGR3 antibody (BioLegend, 302061) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 3a
BioLegend FCGR3 antibody (BioLegend, 302039) was used in flow cytometry on human samples (fig 3a). J Exp Med (2019) ncbi
mouse monoclonal (3G8)
  • mass cytometry; human; loading ...; fig 2j
BioLegend FCGR3 antibody (Biolegend, 302002) was used in mass cytometry on human samples (fig 2j). Cell (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 6b
BioLegend FCGR3 antibody (BioLegend, 302044) was used in flow cytometry on human samples (fig 6b). Immunity (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s5a
BioLegend FCGR3 antibody (Biolegend, 302012) was used in flow cytometry on human samples (fig s5a). Breast Cancer Res Treat (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 2a
BioLegend FCGR3 antibody (Biolegend, 302035) was used in flow cytometry on human samples (fig 2a). elife (2019) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 1c
BioLegend FCGR3 antibody (BioLegend, 302025) was used in flow cytometry on human samples (fig 1c). J Exp Med (2018) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 1a
BioLegend FCGR3 antibody (Biolegend, 302002) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s2d
BioLegend FCGR3 antibody (BioLegend, 302016) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 7c
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend FCGR3 antibody (BioLegend, 302040) was used in flow cytometry on human samples (fig 7c). Immunity (2017) ncbi
mouse monoclonal (3G8)
  • flow cytometry; rhesus macaque; loading ...; fig 7a
In order to study the efficacy of nanoparticle adjuvants for inducing protective immunity against simian immunodeficiency virus, BioLegend FCGR3 antibody (Biolegend, 3G8) was used in flow cytometry on rhesus macaque samples (fig 7a). J Virol (2017) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the roles of CD16+ monocytes in T-cell activation and B-cell responses in systemic lupus erythematosus, BioLegend FCGR3 antibody (Biolegend, 302012) was used in flow cytometry on human samples (fig 1a). Front Immunol (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig 1c
In order to profile the infiltration levels of immune cell populations in 19 cancer types, BioLegend FCGR3 antibody (Biolegend, 302008) was used in flow cytometry on human samples (fig 1c). Genome Biol (2016) ncbi
mouse monoclonal (3G8)
BioLegend FCGR3 antibody (BioLegend, 302006) was used . Nat Commun (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BioLegend FCGR3 antibody (Biolegend, 3G8) was used in flow cytometry on human samples . PLoS Pathog (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; 1:100; fig 5
BioLegend FCGR3 antibody (Biolegend, 302007) was used in flow cytometry on human samples at 1:100 (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; mouse; 1:200
In order to assess the role of NLRC5 to NK-T-cell crosstalk, BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 5
BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 7
BioLegend FCGR3 antibody (Biolegend, 3G8) was used in flow cytometry on human samples (fig 7). Eur J Immunol (2016) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; loading ...; fig s1b
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend FCGR3 antibody (Biolegend, 3G8) was used in flow cytometry on human samples (fig s1b). J Immunol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3 antibody (Biolegend, 302008) was used in flow cytometry on human samples . J Neuroimmunol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; mouse
In order to compare the initial systemic Env-specific B cell responses of AGMs and rhesus macaques, BioLegend FCGR3 antibody (Biolegend, 3G8) was used in flow cytometry on mouse samples . J Virol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig s3
In order to determine the competitive advantage for human hematopoietic stem cells in vivo provided by CCND1-CDK4-mediated cell cycle progression, BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on human samples (fig s3). J Exp Med (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 1
In order to identify the response to anti-MPO antibodies in the form of increased surface expression of ANCA autoantigens and IL-1beta secretion acting as intermediate monocytes in ANCA vasculitis, BioLegend FCGR3 antibody (Biolegend, 3G8) was used in flow cytometry on human samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3 antibody (BioLegend, 302026) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; rhesus macaque; fig 3
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on rhesus macaque samples (fig 3). J Virol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 4
BioLegend FCGR3 antibody (Biolegend, 3G8) was used in flow cytometry on human samples (fig 4). J Rheumatol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 1
BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on human samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 7
BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on human samples (fig 7). J Immunol (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on human samples . Genes Immun (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3 antibody (Biolegend, 3G8) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to evaluate immune responses by monocyte isolated from young and old adults before and after influenza vaccination, BioLegend FCGR3 antibody (BioLegend, clone3G8) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; rhesus macaque
  • immunohistochemistry; rhesus macaque
In order to examine the diagnostic value of mannose receptor CD206 in HIV and simian immunodeficiency virus encephalitis, BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on rhesus macaque samples and in immunohistochemistry on rhesus macaque samples . J Neuroimmune Pharmacol (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on human samples . Cell Immunol (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend FCGR3 antibody (Biolegend, 3G8) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (3G8)
  • immunohistochemistry - frozen section; rhesus macaque; loading ...
BioLegend FCGR3 antibody (BioLegend, 302005) was used in immunohistochemistry - frozen section on rhesus macaque samples . Mol Ther (2014) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
BioLegend FCGR3 antibody (BioLegend, 3G8) was used in flow cytometry on human samples . Clin Cancer Res (2013) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human
In order to describe protocols for immunostaining and multiparameter flow cytometric analysis of major human antigen-presenting cells in peripheral blood, BioLegend FCGR3 antibody (BioLegend, 302021) was used in flow cytometry on human samples . Nat Protoc (2010) ncbi
Invitrogen
mouse monoclonal (3G8)
  • flow cytometry; rhesus macaque; tbl 1
In order to characterize the role of T-cell depletion and macrophage polarization and infection during splenic damage during SIV infection, Invitrogen FCGR3 antibody (eBioScience, 3G8) was used in flow cytometry on rhesus macaque samples (tbl 1). Am J Pathol (2016) ncbi
mouse monoclonal (3G8)
  • immunoprecipitation; human
Invitrogen FCGR3 antibody (eBioscience, 3G8) was used in immunoprecipitation on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (3G8)
  • flow cytometry; human; fig 8
In order to explore the role of HIV in potentially modulating macrophage function, Invitrogen FCGR3 antibody (eBioscience, 3G8) was used in flow cytometry on human samples (fig 8). Retrovirology (2013) ncbi
Articles Reviewed
  1. Kaminski M, Bendzick L, Hopps R, Kauffman M, Kodal B, Soignier Y, et al. TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity. J Immunother Cancer. 2022;10: pubmed publisher
  2. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  3. Zhu Y, Xie J, Shi J. Rac1/ROCK-driven membrane dynamics promote natural killer cell cytotoxicity via granzyme-induced necroptosis. BMC Biol. 2021;19:140 pubmed publisher
  4. Li D, Edwards R, Manne K, Martinez D, Schäfer A, Alam S, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021;184:4203-4219.e32 pubmed publisher
  5. Hibl B, Dailey Garnes N, Kneubehl A, Vogt M, Spencer Clinton J, Rico Hesse R. Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects. PLoS Negl Trop Dis. 2021;15:e0009427 pubmed publisher
  6. Ukadike K, Ni K, Wang X, Taylor M, LaCava J, Pachman L, et al. IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus. Arthritis Res Ther. 2021;23:153 pubmed publisher
  7. Lu Q, Liu J, Zhao S, Gomez Castro M, Laurent Rolle M, Dong J, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. 2021;54:1304-1319.e9 pubmed publisher
  8. Zong D, Huang B, LI Y, Lu Y, Xiang N, Guo C, et al. Chromatin accessibility landscapes of immune cells in rheumatoid arthritis nominate monocytes in disease pathogenesis. BMC Biol. 2021;19:79 pubmed publisher
  9. Combes A, Courau T, Kuhn N, Hu K, Ray A, Chen W, et al. Global absence and targeting of protective immune states in severe COVID-19. Nature. 2021;591:124-130 pubmed publisher
  10. Thulin N, Brewer R, Sherwood R, Bournazos S, Edwards K, Ramadoss N, et al. Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants. Cell Rep. 2020;31:107642 pubmed publisher
  11. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  12. Muhammad F, Wang D, Montieth A, Lee S, Preble J, Foster C, et al. PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease. Sci Rep. 2019;9:16941 pubmed publisher
  13. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  14. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  15. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  16. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  17. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  18. Janela B, Patel A, Lau M, Goh C, Msallam R, Kong W, et al. A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils. Immunity. 2019;50:1069-1083.e8 pubmed publisher
  19. Guo L, Chen G, Zhang W, Zhou L, Xiao T, Di X, et al. A high-risk luminal A dominant breast cancer subtype with increased mobility. Breast Cancer Res Treat. 2019;175:459-472 pubmed publisher
  20. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher
  21. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  22. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  23. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  24. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  25. Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed publisher
  26. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  27. Senbabaoglu Y, Gejman R, Winer A, Liu M, Van Allen E, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17:231 pubmed
  28. Geng S, Chen K, Yuan R, Peng L, Maitra U, Diao N, et al. The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis. Nat Commun. 2016;7:13436 pubmed publisher
  29. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  30. Williams D, Engle E, Shirk E, Queen S, Gama L, Mankowski J, et al. Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection. Am J Pathol. 2016;186:2068-2087 pubmed publisher
  31. Parameswaran R, Ramakrishnan P, Moreton S, Xia Z, Hou Y, Lee D, et al. Repression of GSK3 restores NK cell cytotoxicity in AML patients. Nat Commun. 2016;7:11154 pubmed publisher
  32. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  33. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed publisher
  34. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed publisher
  35. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  36. WILLIAMS K, KILLEBREW D, Clary G, Seawell J, Meeker R. Differential regulation of macrophage phenotype by mature and pro-nerve growth factor. J Neuroimmunol. 2015;285:76-93 pubmed publisher
  37. Amos J, Himes J, Armand L, Gurley T, Martinez D, Colvin L, et al. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys. J Virol. 2015;89:9485-98 pubmed publisher
  38. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed publisher
  39. O Brien E, Abdulahad W, Rutgers A, Huitema M, O Reilly V, Coughlan A, et al. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies. Sci Rep. 2015;5:11888 pubmed publisher
  40. Chalan P, Bijzet J, Huitema M, Kroesen B, Brouwer E, Boots A. Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis. PLoS ONE. 2015;10:e0132436 pubmed publisher
  41. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  42. Weldon A, Moldovan I, Cabling M, Hernandez E, Hsu S, Gonzalez J, et al. Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. J Rheumatol. 2015;42:749-59 pubmed publisher
  43. Chauhan A, Chen C, Moore T, DiPaolo R. Induced expression of FcγRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-γhigh subset. J Biol Chem. 2015;290:5127-40 pubmed publisher
  44. Hünniger K, Bieber K, Martin R, Lehnert T, Figge M, Löffler J, et al. A second stimulus required for enhanced antifungal activity of human neutrophils in blood is provided by anaphylatoxin C5a. J Immunol. 2015;194:1199-210 pubmed publisher
  45. Hartung E, Becker M, Bachem A, Reeg N, Jäkel A, Hutloff A, et al. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1. J Immunol. 2015;194:1069-79 pubmed publisher
  46. Presnell S, Al Attar A, Cichocki F, Miller J, Lutz C. Human natural killer cell microRNA: differential expression of MIR181A1B1 and MIR181A2B2 genes encoding identical mature microRNAs. Genes Immun. 2015;16:89-98 pubmed publisher
  47. Mandl M, Schmitz S, Weber C, Hristov M. Characterization of the CD14++CD16+ monocyte population in human bone marrow. PLoS ONE. 2014;9:e112140 pubmed publisher
  48. Mohanty S, Joshi S, Ueda I, Wilson J, Blevins T, Siconolfi B, et al. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis. 2015;211:1174-84 pubmed publisher
  49. Holder G, McGary C, Johnson E, Zheng R, John V, Sugimoto C, et al. Expression of the mannose receptor CD206 in HIV and SIV encephalitis: a phenotypic switch of brain perivascular macrophages with virus infection. J Neuroimmune Pharmacol. 2014;9:716-26 pubmed publisher
  50. Jiang B, Wu X, Li X, Yang X, Zhou Y, Yan H, et al. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Cell Immunol. 2014;290:10-20 pubmed publisher
  51. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  52. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  53. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  54. Babu R, Brown A. A consensus surface activation marker signature is partially dependent on human immunodeficiency virus type 1 Nef expression within productively infected macrophages. Retrovirology. 2013;10:155 pubmed publisher
  55. Chicoine L, Rodino Klapac L, Shao G, Xu R, Bremer W, Camboni M, et al. Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin ?2 surrogates. Mol Ther. 2014;22:713-24 pubmed publisher
  56. Wiernik A, Foley B, Zhang B, Verneris M, Warlick E, Gleason M, et al. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res. 2013;19:3844-55 pubmed publisher
  57. Fung E, Esposito L, Todd J, Wicker L. Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc. 2010;5:357-70 pubmed publisher